Regulation of urokinase expression in the developing avian heart: A role for the Ets-2 transcription factor

Mechanisms of Development

Volumn 68, Issue 1-2, 1997, Pages 127-137

  Majka, Susan M ^a   McGuire, Paul G ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Ets 2; Transcription Factors; Urokinase

Indexed keywords

TRANSCRIPTION FACTOR; UROKINASE;

ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL TRANSFORMATION; CROSS LINKING; DNA BINDING; ENZYME REGULATION; ENZYME SUBSTRATE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE DELETION; HEART DEVELOPMENT; MORPHOGENESIS; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DNA-BINDING PROTEINS; EMBRYO, NONMAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; MESODERM; MYOCARDIUM; PROMOTER REGIONS (GENETICS); PROTEINS; PROTO-ONCOGENE PROTEIN C-ETS-2; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; QUAIL; REGULATORY SEQUENCES, NUCLEIC ACID; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031450085     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4773(97)00138-X     Document Type: Article

References (44)

1. Bernanke D.H., Markwald R.R. Migratory behavior of cardiac cushion tissue cells in a collagen lattice culture system. Dev. Biol. 91:1982;235-246.
2. Blasi F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays. 15:1993;105-111.
3. Bhat N.K., Fisher R.J., Fujiwara S., Ascione R., Papas T.S. Temporal and tissue specific expression of mouse ets genes. Proc. Natl. Ac aspects of mesenchymal-epithelial interactions. Annu. Rev. Cell Biol. 9:1987;511-540.
4. Boulukos K.E., Pognonec P., Begue A., Galibert F., Gesquiere J.C., Stehelin D., Ghysdael J. Identification in chickens of an evolutionarily conserved cellular ets-2 gene (c-ets-2) encoding nuclear proteins related to the products of the c-ets proto-oncogene. EMBO. 7:1988;697-705.
5. Carmi R., Boughman J.A., Ferencz C. Endocardial cushion defect: further studies of 'isolated versus syndromic' occurrence. Am. J. Med. Genet. 43:1992;569-575.
6. Chin C.C., Gandour-Edwards R., Oltjen S., Choy M. Fate of the atrioventricular endocardial cushions in the developing chick heart. Pediatr. Res. 32:1992;390-393.
7. Crepieux P., Coll J., Stehelin D. The Ets family of proteins: weak modulators of gene expression in quest for transcriptional partners. Crit. Rev. Oncogen. 5:1994;615-638.
8. Edwards D.R., Rocheleau H., Sharma R.R., Wills A.J., Cowie A., Hassell J.A., Heath J.K. Involvement of AP-1 and PEA3 binding sites in the regulation of murine tissue inhibitor of murine tissue inhibitor of metalloproteinases-1 (TIMP) transcription. Biochim. Biophys. Acta. 1171:1992;41-55.
9. Fisher C. L, Ghysdael J., Cambier J.C. Ligation of membrane Ig leads to calcium mediated phosphorylation of the proto-oncogene product, Ets-1. J. Immunol. 146:1991;1743-1749.
10. Gutman A., Wasylyk B. The collagenase gene promoter contains a TPA and oncogene responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO. 9:1990;2241-2246.
11. Hay E.D. Epithelial-mesenchymal transitions. Seminars in Developmental Biology. 1:1990;347-356.
12. Hiltgen G.G., Markwald R.R., Litke L.L. Morphogenetic alterations during endocardial cushion development in the Trisomy 16 (Down Syndrome) mouse. Pediatr. Cardiol. 17:1996;21-30.
13. Hromas R., Klemsz M. The Ets oncogene family in development, proliferation, and neoplasia. Int. J. Haematol. 59:1994;257-265.
14. Huang J.-X., Potts J.D., Vincent E.B., Weeks D.L., Runyan R.B. Mechanisms of cell transformation in the embryonic heart. Ann. N. Y. Acad. Sci. 752:1995;317-330.
15. Icardo J.M., Fernandez-Teran A. Morphological study of ventricular trabeculation in the embryonic chick heart. Acta Anat. 130:1987;264-274.
16. Janknecht R., Nordheim A. Gene regulation by ETS proteins. Biochim. Biophys. Acta. 1155:1993;346-356.
17. Korenberg, J., 1991. Down Syndrome phenotype mapping. In: The Morphogenesis of Down Syndrome. Wiley-Liss, New York, pp. 43-52.
18. Kola I., Brookes S., Green A.R., Garber R., Tymms M., Papas T.S., Seth A. The Ets-1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc. Natl. Acad. Sci. USA. 90:1993;7588-7592.
19. Krug E.L., Mjaatvedt C.H., Markwald R.R. Extracellular matrix from early embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation. Dev. Bio. 165:1987;348-355.
20. Leslie N.D., Kessler C.A., Bell S.M., Degen J.L. The chicken urokinase type plasminogen activator gene. J. Biol. Chem. 265:1990;1339-1344.
21. Lyons R.M., Gentry L.E., Purchio A.F., Moses H.L. Mechanisms of activation of latent recombinant transforming growth factor β-1 by plasmin. J. Cell Biol. 110:1990;1361-1367.
22. Marino B., Vairo U., Corno A. Atrioventricular canal in Down syndrome. Prevalence of associated cardiac malformations compared with patients without Down syndrome. Am. J. Dis. Child. 144:1990;1120-1122.
23. Markwald R.R., Fitzharris T.P., Manasek F.J. Structural analysis of endocardial cushion development. Am. J. Anal. 148:1977;85-120.
24. Maroulakou I.G., Papas T.S., Green J.E. Differential expression of ets-1 and ets-2 protooncogenes during murine embryogenesis. Oncogene. 9:1994;1551-1565.
25. McGuire P.G., Orkin R.W. Urokinase activity in the developing avian heart: a spatial and temporal analysis. Dev. Dynamics. 193:1992;24-33.
26. McGuire P.G., Alexander S.M. Urokinase expression during the epithelial-mesenchymal transformation of the Avian Somite. Dev. Dyn. 194:1992;193-197.
27. McGuire P.G., Alexander S.M. Inhibition of urokinase synthesis and cell surface binding alters the motile behavior of embryonic endocardial-derived mesenchymal cells in vitro. Development. 118:1993;931-939.
28. Miyabara, S., 1990. Cardiovascular malformations of mouse trisomy 16: pathogenetic evaluation as an animal model for human trisomy 21. In: Clark, E.B., Tako, A. (Eds.), Developmental Cardiology: Morphogenesis and Function. Futura Press, New York, pp. 409-430.
29. Nakajima Y., Krug E.L., Markwald R.R. Myocardial regulation of transforming growth factors expression by outflow tract endothelium in the early embryonic chick heart. Dev. Biol. 164:1994;615-626.
30. Naldini L., Tamagnone L., Vigna E., Sachs M., Hartman G., Birchmeier W., Daikuhara Y., Tsubouchi H., Blasi F., Comoglio P.M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO. 11:1992;4825-4833.
31. Nerlov C., DeCesare D., Pergola F., Caracciolo A., Blasi F., Johnsen M., Verde P. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO. 11:1992;4573-4582.
32. Nerlov, C., Rorth, P., Blasi., F., Johnsen, M., 1991. Essential AP-1 and PEA 3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6, 1583-1592.
33. Pardanaud L.C., Altman C., Kitos P., Dieterlen-Lievre F., Buck C.A. Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. Development. 100:1987;339-349.
34. Potts J.D., Runyan R.B. Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor β Dev. Biol. 134:1989;392-401.
35. Rorth P., Nerlov C., Blasi F., Johnsen M. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucleic Acids Res. 18:1990;5009-5017.
36. Sacchi N., Nalbantoglu J., Sergovich F.R., Papas T.S. Human ETS2 gene on chromosome 21 is not rearranged in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 85:1988;7675-7679.
37. Stacey K.J., Fowles L.F., Colman M.S., Ostrowski M.C., Hume D.A. Mol. Cell Biol. 15:1995;3430-3441.
38. Sumarsono S.H., Wilson T.J., Tymms M.J., Venter D.J., Corrick C.M., Kola R., Lahoud M.H., Pappas T.S., Seth A., Kola I. Down Syndrome-like skeletal abnormalities in Ets-2 transgenic mice. Nature. 379:1996;534-537.
39. Wang C.Y., Petryniak B., Ho I.C., Thompson C.B., Leiden J.M. Evolutionarily conserved Ets family members display distinct DNA binding specificities. J. Exp. Med. 175:1992;1391-1399.
40. Wasylyk B., Hahn S.L., Giovane A. The Ets family of transcription factors. Eur. J. Biochem. 211:1993;7-18.
41. Wasylyk B., Wasylyk C., Flores P., Begue A., Leprince D., Stehelin D. The c-ets protooncogenes encode transcription factors that cooperate with c-fos and c-jun for transcriptional activation. Nature. 346:1990;191-193.
42. Watson D.K., Smith M.J., Kozak C., Reeves R., Gearhart J., Nunn M.F., Nash J., Fowle W., Duesburg P., Papas T.S., O'Brien S.J. Conserved chromosome position of dual domains of the ets protooncogene in cats, mice, and humans. Proc. Natl. Acad. Sci. USA. 83:1986;1792-1796.
43. Wernert N., Raes M.B., Lassalle P., Dehouck M.P., Gosselin B., Vandenbunder B., Stehelin D. C-ets proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140:1992;119-127.
44. Zacchei A.M. Lo sviluppo embrionale della quagglia giapponese (Coturnix coturnix japonica). Arch. Ital. Anat. Embriol. 66:1961;36-72.